The dysregulation of a subset of microRNAs in triple-negative breast cancer is associated with poor survival following neoadjuvant chemotherapy
Findings suggest that the downregulation of specific miRNAs in samples from patients with TNBC may serve as a potential biomarker for predicting the response to neoadjuvant chemotherapy.